SiteOne Therapeutics Report issue

For profit Phase 1
Founded: Bozeman MT United States (2010)

Organization Overview

First Clinical Trial
2020
NCT04475198
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

SiteOne Therapeutics, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

st-2427 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1